Kenya has called for equitable access to future TB vaccines for high-burden countries
Geneva, May19,2026 Kenya has called for equitable access to future TB vaccines for high-burden countries, stronger inclusion of African populations in clinical trials, sustainable financing, and regional manufacturing to ensure timely and affordable access to life-saving vaccines.
Speaking during the Fourth High-Level Strategic Roundtable Discussion of the TB Vaccine Accelerator Council, Principal Secretary for Public Health and Professional Standards, Mary Muthoni, said Kenya is proactively preparing for future TB vaccine rollout through strengthened regulatory systems, vaccine delivery planning, and exploration of local manufacturing opportunities.
The PS noted that Kenya has reduced TB incidence by 45 percent and mortality by 58 percent since 2015 through expanded diagnostics, wider treatment access, and integrated TB-HIV services, but cautioned that TB remains a major public health challenge, with nearly one in five cases still missed.
Kenya reaffirmed its commitment to ending TB through stronger prevention, early diagnosis, treatment, innovation, and accelerated access to effective vaccines.